Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine + Cisplatin vs Gemcitabine + Paclitaxel in Advanced TNBC
NCT01287624Phase 3Completed
- Sponsor
- Fudan University
- Start
- Jan 2011
- Primary completion
- Mar 2014
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Cisplatin micelle injection (HA132) in triple-negative breast cancer (TNBC), sponsored by Fudan University. Started Jan 2011; status: completed.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT01287624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01287624.